Skip to main content
News Icon

News categories: Honors & Funding

ERC Grant for Elvira Mass

Dr. Elvira Mass from the LIMES Institute and member of the Cluster of Excellence ImmunoSensation of the University of Bonn receives a coveted Starting Grant from the European Research Council (ERC). This will mean a subsidy of 1.5 million euros over the next five years. The scientist wants to investigate the influence of nanoplastics on the development of neurological diseases.

With Starting Grants, the European Research Council honors outstanding junior researchers. The funding from Brussels will amount to 1.5 million euros over the next five years. Dr. Elvira Mass wants to investigate an omnipresent but understudied environmental risk for our immune system: the pollution caused by small plastic particles. "These particles, which decompose over time into micro- and nanoplastics have been detected in a variety of ecosystems," says Dr. Elvira Mass. "They are speculated to enter and spread in the food web all the way to humans."


Contact

Dr. Elvira Mass

LIMES-Institut der Universität Bonn

Tel. 02 28 / 73 - 6 28 48

E-Mail: emass@uni-bonn.de

Related news

News Icon

News categories: Honors & Funding

Otto-Westphal Thesis Prize for Jonas Schulte-Schrepping

The German Society for Immunology e.V. (DGfI) anually honours one of its members by awarding the Otto-Westphal Thesis Prize. This year, Jonas Schulte-Schrepping from the research group of Prof. Joachim Schultze at the DZNE was selected for his PhD thesis on the systemic immune response to COVID-19. The prize is endowed with a prize money of 1,500 EUR.
View entry
DGORH Honours

News categories: Honors & Funding

Honours for research orthopaedic rheumatology

The German Society for Orthopaedic Rheumatology (DGORh) awards the Arthur Vick Prize annually. The award serves to promote research in the field of orthopaedic rheumatology. The prize is endowed with 7,000 euros.
View entry
News Icon

News categories: Honors & Funding

Acute lymphoblastic leukemia in children

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and poses a significant threat to health. The joint research project "EDI-4-ALL" (Early detection and interception for acute lymphoblastic leukemia) aims at the development of new analysis tools for the early detection of a genetic predisposition to ALL in newborns. The project is a joint endeavour by leading scientists from the Universities of Düsseldorf, Gießen and Bonn, the Charité Berlin and Zytovision, under participation of Prof. Alksandra Pandyra. The project is funded with a total of 2.6 million Euros by the BMBF.
View entry

Back to the news overview